Reported 2 months ago
Cathie Wood, CEO of Ark Invest, bought shares of Moderna after its stock fell 27% due to a lowered revenue forecast. Despite challenges faced by the company, including slower-than-expected sales and reliance on its initial coronavirus vaccine, Moderna aims to launch multiple new products that could significantly increase its revenue in the coming years. While the stock may not experience immediate growth, it presents a long-term investment opportunity as it builds a broader product portfolio.
Source: YAHOO